A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Danaher Corp stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 5,732 shares of DHR stock, worth $1.59 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,732
Previous 7,652 25.09%
Holding current value
$1.59 Million
Previous $2.25 Million 35.28%
% of portfolio
0.17%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$237.11 - $299.66 $455,251 - $575,347
-1,920 Reduced 25.09%
5,732 $1.45 Million
Q1 2022

May 09, 2022

SELL
$257.27 - $315.76 $57,885 - $71,046
-225 Reduced 2.86%
7,652 $2.25 Million
Q4 2021

Jan 10, 2022

BUY
$292.08 - $329.01 $2.08 Million - $2.34 Million
7,126 Added 948.87%
7,877 $2.59 Million
Q2 2021

Aug 23, 2021

SELL
$225.08 - $271.69 $112,540 - $135,845
-500 Reduced 39.97%
751 $202,000
Q2 2020

Jul 31, 2020

BUY
$128.7 - $176.83 $161,003 - $221,214
1,251 New
1,251 $249,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $202B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Dixon Hubard Feinour & Brown Inc Portfolio

Follow Dixon Hubard Feinour & Brown Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.